MORGAN SMITHER: Open Payments
NPI 1740842715 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 24 payments from 10 companies in 2025. Trend: 2023 $278 · 2024 $795 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $204 |
| Corium, LLC | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $56 |
| Lundbeck LLC | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Neos Therapeutics, LP | 2 | $36 |
| Noven Therapeutics, LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, REXULTI, Azstarys, AUSTEDO XR, HETLIOZ, Adzenys XR-ODT, Xelstrym, SPRAVATO.
Industry payments across KY — which companies pay providers there.
